ARCHIVES

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

This article is from The Cancer Letter archive.

Vol. 05 No. 02 | January 12, 1979

Download PDF Visit The Full Archive

Related Articles

Early Treatment with CMX001 Can Help Prevent CMV Infection

September 27, 2013

In Brief: Bruce Chabner, DC director, To Leave NCI Next Spring For Position At Mass General

October 28, 1994

New Subcontracts Planned In Bioassay Program Run by Traco-JITCO

May 23, 1975

Give Young Women Data, Not Guidelines, Advisors Tell NCI; consensus For Over 50

October 29, 1993

In Brief: Murphy New ACS President, Robert McKenna Named President Elect Gehan Receives Gottlief Award

November 18, 1983

Program Announcement.

July 4, 2003